BlackRock’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-91,578
| Closed | -$278K | – | 5331 |
|
|
2023
Q4 | $278K | Buy |
91,578
+5,994
| +7% | +$18.2K | ﹤0.01% | 4484 |
|
|
2023
Q3 | $243K | Sell |
85,584
-2,823
| -3% | -$8.02K | ﹤0.01% | 4560 |
|
|
2023
Q2 | $230K | Buy |
88,407
+7,161
| +9% | +$18.6K | ﹤0.01% | 4611 |
|
|
2023
Q1 | $148K | Buy |
81,246
+1,902
| +2% | +$3.46K | ﹤0.01% | 4783 |
|
|
2022
Q4 | $131K | Sell |
79,344
-117,568
| -60% | -$194K | ﹤0.01% | 4879 |
|
|
2022
Q3 | $376K | Sell |
196,912
-4,592
| -2% | -$8.77K | ﹤0.01% | 4717 |
|
|
2022
Q2 | $601K | Sell |
201,504
-463,242
| -70% | -$1.38M | ﹤0.01% | 4624 |
|
|
2022
Q1 | $2.51M | Buy |
664,746
+122,324
| +23% | +$461K | ﹤0.01% | 4214 |
|
|
2021
Q4 | $6.17M | Buy |
542,422
+151,023
| +39% | +$1.72M | ﹤0.01% | 3840 |
|
|
2021
Q3 | $6.87M | Buy |
+391,399
| New | +$6.87M | ﹤0.01% | 3780 |
|